We sit down with you and build your perfect lead list. Book a call with founders.

Etiome Analysis: $50M Raised

What is Etiome?

Preemptive medicines to disrupt disease progression
Location
Cambridge, United States
Employees
11-50
Founded
2021

Product Features & Capabilities

  • Biostaged Medicines for disease prevention
  • Stage-specific therapies for targeted populations

Find more companies like Etiome

VC-backed University Spinouts

Financial Overview

$50MTotal Raised
Series A
Want to research more data points on Etiome?
Start with Extruct

Platform Links